# Arthrone

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arthrone

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.arthrone.com/
- Total disclosed funding: $36M
- Latest round: Series C (Apr 3, 2026)
- Investors on record: 10

## About

Established in 2017, and based in Beijing, China, Beijing Arthrone Technology Co., Ltd., trading as Arthrone, is a medical equipment company that focuses on the design, development, production, and sales of medical ceramic products. The company's R&D team members include 1 doctor and 6 masters. Arthrone has applied for 53 patents, including 5 granted invention patents and 21 granted utility model patents. The company has established two production lines, equipped with production equipment, such as five-axis machining centers, and multi-functional sandblasting and polishing machines. Besides, the company has testing centers. In April 2026, Arthrone raised nearly CNY 150 million in series C3 funding from E-Town International Industrial Investment, E-town Sun Fund, MED-FINE Capital and Galaxy Capital Management.

The company's products can be divided into artificial joint products, artificial spine products, sports medicine products, and dental products. Joint products include knee prosthesis, zirconia hip prosthesis systems, and alumina hip prosthesis systems. Products can be used in orthopedics, sports medicine, dentistry, and other fields.

The company generates revenue by providing medical ceramic products.

The company will use the latest funding to deepen R&D in next-generation orthopedic ceramic implants, expand automated production capacity for high-performance ceramics, accelerate domestic and international clinical registration and market entry (especially in Europe and the U.S.), and strengthen the upstream–downstream ecosystem to promote localization of key materials.

## Funding rounds

- Series C, Apr 3, 2026, $22M — Galaxy Capital Management, E-Town International Industrial Investment, MED-FINE Capital, E-town Sun Fund
- Series C, Aug 25, 2023, $14M — CDIB Capital Group, SAIF Partners
- Series B, Mar 10, 2021 — Cowin Capital, E-town Sun Fund, HM Capital, Dezhou Caijin Capital
- Angel, Sep 6, 2017 — MED-FINE Capital, Kuimu Capital

## Investors

- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Angel, Series C
- Kuimu Capital — Angel
- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series B
- E-town Sun Fund (https://capitalatlas.ai/funds/e-town-sun-fund) — Series B, Series C
- HM Capital (https://capitalatlas.ai/funds/hm-capital) — Series B
- Dezhou Caijin Capital (https://capitalatlas.ai/funds/dezhou-caijin-capital) — Series B
- CDIB Capital Group (https://capitalatlas.ai/funds/cdib-capital-group) — Series C
- SAIF Partners (https://capitalatlas.ai/funds/saif-partners) — Series C
- Galaxy Capital Management (https://capitalatlas.ai/funds/galaxy-capital-management) — Series C
- E-Town International Industrial Investment (https://capitalatlas.ai/funds/e-town-international-industrial-investment) — Series C